PATENT CLAIM ANALYSIS

Application Number: 16310221
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "265100"]

Abstract:
A pyrrolopyrimidine comprising a cyclopentyi substituent. The present invention specifically relates to a compound represented by formula. A and a stereoisomer and pharmaceutically acceptable salt thereof. The invention further relates to a method for manufacturing the pyrrolopyrimidine comprising the cyclopentyl substituent represented by formula A, a pharmaceutical composition, and an application of the compound in treating a disease induced by Janus kinase.

Claim (Index 10):
A method for treating a disease mediated by Janus kinase, comprising administering to a patient the pharmaceutical composition according to  claim 5 .

Metadata:
- Claim Count in Document: 3.0
- Percentile: 98.0
- Lexical Diversity: 1.65854
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15536648', '15767508', '15984747', '16310369', '12872925']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6796920630833807
- 35 USC 102 Novelty (BERT): 0.5434584590269067
- Combined Prediction Score: 0.6660687026777333
- Mean Citation Score: 321.015822
- Max Citation Score: 380.02322
- Similarity Product: 229.0325632325411

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test